WebHistorical PS ratio values for Fortress Biotech (FBIO) over the last 10 years. The current P/S ratio for Fortress Biotech as of April 07, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide WebPrice/Book: A financial ratio used to compare a company's current market price to its book value. Price/Earnings: Latest closing price divided by the earnings-per-share based on the trailing 12 months. Companies with negative earnings receive an "NE."
Initial Public Offerings: Sales Statistics Through 2024
Web1.3 East India Pharmaceutical Works Limited Price/Book Ratio ; 1.4 East India Pharmaceutical Works Limited Price/Earning Ratio ; 1.5 East India Pharmaceutical Works Limited Net Profit Margin; 1.6 East India Pharmaceutical Works Limited EV / EBITDA ; 1.7 East India Pharmaceutical Works Limited Market Cap/Sales ; 1.8 East India … WebApr 11, 2024 · Biotech is a sector constantly innovating and changing. It is also more technical and complex than most, so the public at large is often oblivious to the radical discoveries made to improve health and save lives. ... It went from a price of $0.11/share in 1984 to a recent price in the $225-$285/share range in 2024. ... Even if this ratio is ... earn extra income while working full time
Biopharma valuations—onward and upward? McKinsey
WebHistorical PS ratio values for UNITY Biotechnology (UBX) over the last 10 years. The current P/S ratio for UNITY Biotechnology as of March 02, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide WebIn depth view into XBI (SPDR® S&P Biotech ETF) including performance, dividend history, holdings and portfolio stats. ... Forecasted Price to Sales Ratio: Upgrade: Forecasted Price to Book Ratio: Upgrade: As of April 06, 2024. Growth Estimates. Forecasted 5 Yr Earnings Growth: Upgrade: Forecasted Book Value Growth: WebPrice to earnings ratio Comment: Price to earnings ratio for the Biotechnology & Pharmaceuticals Industry Biotechnology & Pharmaceuticals Industry's current Price to earnings ratio has decreased due to shareprice contraction of -4.13 %, from beginning of the and due to the sequtial net income for the trailig twelve month period contraction of … earn extra money for the holidays